Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section F, Structural Biology Communications|May 3, 2018
Crystal structures of human CK2α2 in new crystal forms arising from a subtle difference in salt concentrationMasato Tsuyuguchi, Tetsuko Nakaniwa, Takayoshi Kinoshita
Acta Crystallographica. Section F, Structural Biology Communications|July 9, 2019
A promiscuous kinase inhibitor delineates the conspicuous structural features of protein kinase CK2a1Masato Tsuyuguchi, Tetsuko Nakaniwa, Masaaki Sawa, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2019
Structural insights for producing CK2α1-specific inhibitorsMasato Tsuyuguchi, Tetsuko Nakaniwa, Akira Hirasawa, et al.
Biochemical and Biophysical Research Communications|September 21, 2022
Bivalent binding mode of an amino-pyrazole inhibitor indicates the potentials for CK2α1-selective inhibitorsAsaka Ikeda, Masato Tsuyuguchi, Daisuke Kitagawa, et al.
Chemical & Pharmaceutical Bulletin|September 1, 2024
Compounds Designs of CK2α Inhibitors Derived from Virtual Screening Hit Compounds by Computational Chemistry with CrystallographyShinya Nakamura, Keiji Nishiwaki, Masato Tsuyuguchi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|April 24, 2021
The structure of POMGNT2 provides new insights into the mechanism to determine the functional O-mannosylation site on α-dystroglycanRieko Imae, Naoyuki Kuwabara, Hiroshi Manya, et al.
Chemical & Pharmaceutical Bulletin|July 2, 2023
Design, Synthesis and Structure-Activity Relationship Studies of Protein Kinase CK2 Inhibitors Containing a Purine ScaffoldKeiji Nishiwaki, Shinya Nakamura, Kenji Yoshioka, et al.
RSC Medicinal Chemistry|April 26, 2024
Enhanced inhibitory activity of compounds containing purine scaffolds compared to protein kinase CK2α considering crystalline waterKeiji Nishiwaki, Shiori Nakatani, Shinya Nakamura, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Method for Preparing Recombinant Galectin-2 Protein without Escherichia coli-Specific Post-translational ModificationsMayumi Tamura, Norihiko Fujii, Tomoharu Takeuchi, et al.
Mabs|May 13, 2025
Structural and biochemical differences between non-catalytic and catalytic antibodiesTaizo Uda, Ryuichi Kato, Yasuteru Shigeta, et al.
Pageof 2